Immune-checkpoint inhibitors and neurological adverse events

Lancet Neurol. 2023 Dec;22(12):1093-1094. doi: 10.1016/S1474-4422(23)00413-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Neoplasms*

Substances

  • Immune Checkpoint Inhibitors